Miltenyi Biotec
Miltenyi Biotec is a global biotechnology company headquartered near Cologne in Bergisch Gladbach, Germany. The company is a provider of products and services that support scientists, clinical researchers, and physicians across basic research, translational research, and clinical applications. The company offers solutions covering techniques of sample preparation, cell separation, cell sorting, flow cytometry, cell culture, molecular analysis, clinical applications and small animal imaging. Miltenyi Biotec has more than 3,000 employees in 28 countries and more than 17,000 products. Products. Miltenyi Biotec products have been cited in more than 20,000 publications and used in more than 35.000 clinical treatments  to date. Many of the publications that have cited Miltenyi Biotec products can be accessed through CiteAb, an antibody search engine which lists 4591 Miltenyi Biotec products. Miltenyi Biotec instruments, reagents and services support basic research, clinical research, and the translation of basic research findings into clinical applications that enhance human health and treat severe disease. Its product portfolio addresses a complete range of techniques from bench to bedside. Services offered by Miltenyi Biotec include gene expression analysis and contract production of biologicals according to GMP guidelines. Miltenyi Biotec technologies are used in applications concerned with accessing, analyzing, and utilizing  primary and primary-derived cells – across basic research, translational research, and clinical applications. Examples of these applications include sample preparation, cell separation, cell sorting, flow cytometry, molecular applications, cell culture up to GMP grade, preclinical imaging, clinical-grade cell preservation, and clinical-scale cell processing. The company’s reagents and devices are used primarily in the research areas of immunology, stem cell biology, neuroscience and cancer. Sample Preparation. Miltenyi Biotec offers instruments, tools and reagents to facilitate sample preparation. Application areas. Miltenyi Biotec products are used commonly in the application areas of immunology, stem cell biology, neuroscience and cancer. Their  products are used from basic research to clinical applications and are designed to support the successful translation of findings into practical applications that enhance human health and well being. Enabling translational research is a major mission of the company, as is advancing cellular therapy. The company’s products aim to support the development of cellular therapies and make cellular therapy a more viable reality for more patients. Structure. Miltenyi Biotec is a limited liability company (referred to as GmbH in Germany). The officers of the company are Stefan Miltenyi (Founder and President), Dr. Boris Stoffel, Norbert Hentschel, Dr. Juergen Schmitz , Dr. Anoon Overstijns. Headquartered in Bergisch Gladbach with a GMP facility in Teterow, Germany, Miltenyi Biotec also has locations in the United States (two GMP facilities), Great Britain, France, Belgium, Italy, Spain, China, Australia, Japan, The Netherlands, Singapore and Sweden. The company has more than 3,500 employees worldwide (approx. 800 in the United States). The North American Divisions are supported by Miltenyi Biotec North America, which provides all central services to the North American Divisions. Controversies. In March 2022, due to the Russian Invasion of Ukraine, Miltenyi suspended supplies of CAR-T therapy equipment to Russian children's hospital, leaving  patients with incurable tumors for which all other possibilities have been exhausted with no treatment options. While the treatment was available, 90% of child patients were achieving remission, with at least 54 lives saved since 2018.